ArticleCPT: pharmacometrics & systems pharmacology2025

Evaluation of the Drug-Drug Interaction Potential of the GlyT1 Inhibitor Iclepertin (BI 425809): A Physiologically Based Pharmacokinetic (PBPK) Modeling Approach.

Elin M Matsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.